canada semaglutide patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo Nordisk lets Canadian patent

A temperature monitor can help ensure that the medication stays within the recommended range

Even 20-30 minutes of walking daily helps

During dose escalation (weeks 1 to 20) Side effects are most common and most intense during this period

Children under age 18: Semaglutide has not been studied in children so it is unknown whether it is effective and safe in young people

For patients interested in financing options, the tirzepatide Afterpay complete guide covers platforms that do offer installment payment structures for GLP-1 medications

[1] [2] While effective for glycemic control and weight loss, semaglutide can delay gastric emptyinga pharmacologic effect that may pose perioperative considerations